Manali Petrochemicals Subsidiary Inaugurates Manufacturing Facility in Chennai
Manali Petrochemicals' subsidiary PennWhite India Private Limited has inaugurated its manufacturing facility at Oragadam, Chennai on 29 April 2026, marking a strategic expansion into foam control chemistry production. The ISO 9001 certified facility, built within 18 months, will serve Indian and Asian markets while maintaining the same quality standards as PennWhite's UK operations.

*this image is generated using AI for illustrative purposes only.
Manali Petrochemicals has achieved a significant milestone through its subsidiary PennWhite India Private Limited, which successfully inaugurated its manufacturing facility at Oragadam, Chennai, Tamil Nadu on 29 April 2026. This development marks an important expansion in the company's operational capabilities and manufacturing infrastructure for specialty chemicals.
Facility Details and Specifications
The newly opened plant at Oragadam represents a strategic investment by PennWhite India Private Limited to enhance its production capacity for foam control chemistry. The facility is designed to serve customer requirements in India and the wider Asian markets, operating under the same quality and manufacturing standards as PennWhite's existing facility in the United Kingdom.
| Parameter: | Details |
|---|---|
| Facility Type: | Manufacturing Plant for Foam Control Chemistry |
| Location: | Oragadam, Chennai, Tamil Nadu |
| Inauguration Date: | 29 April 2026 |
| Construction Timeline: | 18 months |
| Certification: | ISO 9001 certified |
Corporate Structure and Background
PennWhite India Private Limited operates as a wholly owned step-down subsidiary of Manali Petrochemicals Limited through PennWhite Limited, UK. The UK entity was acquired by Manali Petrochemicals in November 2022, with the Indian subsidiary incorporated in February 2024 to enhance business development in the Indian and broader Asian market.
Leadership Statements
Devaki Muthiah Chardon, Chairperson of PennWhite Limited (UK), emphasized the strategic importance of the facility: "Our PennWhite India plant represents far more than an expansion of our operations. It establishes a strong and strategic presence for PennWhite in Asia, enabling us to better serve our regional customers while opening the door to new partnerships and opportunities."
Tobias Tasche, Chief Executive Officer of PennWhite Limited, UK, highlighted the facility's role in the company's India strategy: "The inauguration of this facility at Oragadam is a significant step in our India strategy. Since MPL's acquisition of PennWhite in 2022, we have steadily expanded our presence — incorporating PennWhite India in 2024, acquiring a defoamer business in India last year, and now commissioning this plant."
Strategic Market Position
The Chennai facility positions PennWhite India to manufacture over 200 products, including foam control agents under the FoamDoctor® brand, silicone oils, and other specialty chemicals. The company serves customers in over 40 countries across applications including food processing, wastewater treatment, printing, oil industry operations, coatings, manufacturing, and construction. The plant has been awarded ISO 9001 certification, with additional quality and food safety accreditations currently underway.
Historical Stock Returns for Manali Petrochemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.58% | -3.15% | +29.46% | -28.26% | -3.05% | -32.92% |
What production capacity targets has PennWhite India set for its Chennai facility in the next 2-3 years?
How will this Asian expansion impact Manali Petrochemicals' revenue mix and geographic diversification strategy?
Which specific Asian markets beyond India is PennWhite targeting for its FoamDoctor® brand expansion?


































